[{"address1": "295 Rokeby Road", "address2": "Suite 1", "city": "Subiaco", "state": "WA", "zip": "6008", "country": "Australia", "phone": "61 8 6555 2950", "fax": "61 8 6166 0261", "website": "https://argentbiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Argent BioPharma Limited, a multidisciplinary drug development Company, engages in the provision of medicines targeting immunology and neurology worldwide. The company's principal product candidates include CimetrA, which is in phase IIB clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the symptomatic relief of Dementia and Alzheimer. It is also involved in the preclinical development of Irnican for the treatment of Glioblastoma Multiforme; and RGAI03MW01, which focuses on chronic wound treatment. The company has collaboration with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Roby Reuven Zomer", "age": 44, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 272138, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Igor  Bluvstein", "age": 42, "title": "Chief Financial Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Shachar  Shimony", "title": "Group General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Amir  Polak", "title": "Chief Pharmaceutical Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sabina  Suljakovic", "title": "Chief Quality and Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nadya  Lisovoder", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sasha  Friedman", "title": "Deputy CEO", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Yair  Tal", "title": "Chief Information Security Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rowan  Harland", "title": "Company Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ana Arhar Oblak", "title": "Group Financial Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0591, "open": 0.013, "dayLow": 0.013, "dayHigh": 0.013, "regularMarketPreviousClose": 0.0591, "regularMarketOpen": 0.013, "regularMarketDayLow": 0.013, "regularMarketDayHigh": 0.013, "payoutRatio": 0.0, "beta": 0.466, "volume": 1, "regularMarketVolume": 1, "averageVolume": 73, "averageVolume10days": 0, "averageDailyVolume10Day": 0, "bid": 0.0015, "ask": 0.0932, "bidSize": 30000, "askSize": 400, "marketCap": 21373040, "fiftyTwoWeekLow": 0.0105, "fiftyTwoWeekHigh": 0.5683, "priceToSalesTrailing12Months": 72.24722, "fiftyDayAverage": 0.0531236, "twoHundredDayAverage": 0.12424745, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 11841303, "profitMargins": 0.0, "floatShares": 20829697, "sharesOutstanding": 72183200, "heldPercentInsiders": 0.57931, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 361641984, "bookValue": -0.201, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -22616000, "trailingEps": -0.26, "lastSplitFactor": "1:1000", "lastSplitDate": 1698624000, "enterpriseToRevenue": 40.027, "enterpriseToEbitda": -0.629, "52WeekChange": -0.75877553, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 0.0591, "recommendationKey": "none", "totalCash": 718387, "totalCashPerShare": 0.013, "ebitda": -18813208, "totalDebt": 9352199, "quickRatio": 0.08, "currentRatio": 0.155, "totalRevenue": 295832, "revenuePerShare": 0.006, "returnOnAssets": -1.21603, "grossProfits": -375940, "freeCashflow": -2004589, "operatingCashflow": -11031449, "revenueGrowth": -0.993, "grossMargins": -1.27079, "ebitdaMargins": 0.0, "operatingMargins": -2046.4061, "financialCurrency": "AUD", "symbol": "RGTLF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0591, "marketState": "CLOSED", "shortName": "Argent BioPharma Limited", "longName": "Argent BioPharma Limited", "epsTrailingTwelveMonths": -0.26, "fiftyDayAverageChange": 0.0059763975, "fiftyDayAverageChangePercent": 0.112499855, "twoHundredDayAverageChange": -0.065147445, "twoHundredDayAverageChangePercent": -0.5243363, "priceToBook": -0.29402983, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1754611200, "exchange": "PNK", "messageBoardId": "finmb_146284473", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1487773800000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.013 - 0.013", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 73, "fiftyTwoWeekLowChange": 0.0486, "fiftyTwoWeekLowChangePercent": 4.6285715, "fiftyTwoWeekRange": "0.0105 - 0.5683", "fiftyTwoWeekHighChange": -0.50920004, "fiftyTwoWeekHighChangePercent": -0.8960057, "fiftyTwoWeekChangePercent": -75.877556, "earningsTimestampStart": 1753657376, "earningsTimestampEnd": 1754002976, "isEarningsDateEstimate": true, "displayName": "Argent BioPharma", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]